Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children.
Conditions: Attention Deficit Disorder With Hyperactivity; Executive Function Disorder Interventions: Drug: Concerta; Device: Digital therapeutics Sponsors: Lei Lei, MD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Psilocybin in Chronic Low Back Pain and Depression
Conditions: Chronic Low-back Pain; Depression Interventions: Drug: Psilocybin; Drug: Methylphenidate Sponsors: Johns Hopkins University; National Center for Complementary and Integrative Health (NCCIH) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
5-EPIFAT trial protocol: a multi-center, randomized, placebo-controlled trial of the efficacy of pharmacotherapy for fatigue using methylphenidate, bupropion, ginseng, and amantadine in advanced cancer patients on active treatment
DiscussionThe findings of the 5-EPIFAT trial could be helpful to guide clinical decision-making, personalization treatment approach, design of future trials, as well as the development of CRF management guidelines.Trial registrationIRCT.ir IRCT20150302021307N6. Registered on 13 May 2023. (Source: Trials)
Source: Trials - April 3, 2024 Category: Research Source Type: clinical trials
Protocol of a monocentric, double-blind, randomized, superiority, controlled trial evaluating the effect of in-prison OROS-methylphenidate vs. placebo treatment in detained people with attention-deficit hyperactivity disorder (BATIR)
This study is a phase III, double-blinded, randomized, superiority, controlled trial of OROS-MPHvs. placebo. After randomization, the participants will receive 3 months of treatment with OROS-MPH or placebo (1:1 ratio) while incarcerated. Upon release, all participants will be offered the treatment (OROS-MPH) for 1 year but will remain blinded to their initial study group. The study will be conducted at the Division of Prison Health, Geneva, Switzerland, among incarcerated men (n = 150). Measures will include (1) investigator-rated ADHD symptoms, (2) acute events collected by the medical and prison teams, (3) assessment of...
Source: Trials - January 4, 2024 Category: Research Source Type: clinical trials
Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy Humans
Conditions: Healthy Interventions: Drug: Psilocybin; Drug: 3,4 Methylenedioxymethamphetamine; Drug: Methylphenidate Sponsors: University of Zurich Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
Multimodal Brain Imaging of Methylphenidate in Children and Adolescents With ADHD
Conditions: ADHD Interventions: Drug: Methylphenidate; Drug: Placebo Sponsors: Johns Hopkins University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials
Metabolic Mechanisms of the Electrophysiological Biomarkers for Response to Methylphenidate Treatment in Children With ADHD
Conditions: Methylphenidate; Metabolomics Interventions: Drug: methylphenidate Sponsors: National Taiwan University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials
Methylphenidate and Response to Alcohol Cues (MARA) Pilot Study
Conditions: Alcohol Use Disorder; Attention Deficit Hyperactivity Disorder Interventions: Drug: Methylphenidate Pill Sponsors: University of Florida Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2023 Category: Research Source Type: clinical trials
Targeting Drug Memories With Methylphenidate
Conditions: Substance Use Disorder; Cocaine Use Disorder Interventions: Drug: Methylphenidate; Behavioral: Memory reconsolidation; Drug: Placebo Sponsors: Icahn School of Medicine at Mount Sinai; National Institute on Drug Abuse (NIDA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials
